Indicators

Markets:

News

Latest News about JAZZ

Recent news which mentions JAZZ

< Previous 1 2 3 4 5 6 7 8 9

...

Avadel Shareholder Seeks Board Shakeup, Citing Millions Lost On Lumryz

July 01, 2025

Jazz Pharma's Zepzelca Combo Shows Survival Edge In Lung Cancer Study

June 03, 2025

The Analyst Verdict: Jazz Pharmaceuticals In The Eyes Of 11 Experts

June 03, 2025

Earnings Scheduled For May 6, 2025

May 06, 2025

Preview: Jazz Pharmaceuticals's Earnings

May 05, 2025

LUMEN Brings Secret Live Sessions to the World with YouTube Premiere & Debut Single

May 04, 2025

Where Jazz Pharmaceuticals Stands With Analysts

April 10, 2025

DraftKings To Rally Over 29%? Here Are 10 Top Analyst Forecasts For Monday

March 10, 2025

Cancer-Focused Zymeworks' Q4 Earnings Miss Expectations, Reprioritize Resources To Focus On ZW251

March 06, 2025

A Glimpse Into The Expert Outlook On Jazz Pharmaceuticals Through 12 Analysts

March 05, 2025

Jazz Pharma To Buy Chimerix For $935 Million, Strengthening Rare Cancer Pipeline

March 05, 2025

CrowdStrike To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday

February 26, 2025

Earnings Scheduled For February 25, 2025

February 25, 2025

Jazz Legend Bob Holz Nomination-New Album Honoring Larry Coryell

February 15, 2025

This AstraZeneca Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

February 13, 2025

Deep Dive Into Jazz Pharmaceuticals Stock: Analyst Perspectives (9 Ratings)

February 13, 2025

CBD Drug For Tuberous Sclerosis: Caregivers Continue Epidiolex Treatment Citing Seizure Reduction And Cognitive Improvements

December 09, 2024

Axsome Therapeutics' AXS-12 Data For Sleeping Disorder Boosts Confidence In Approval And Market Potential, Analyst Says

November 27, 2024

FDA Greenlights Jazz Pharma's Cancer Drug, A Milestone For Zymework

November 21, 2024

UK Parents Want National Health Service To Allow Cannabis For Children With Epilepsy

November 08, 2024

Jazz Pharmaceuticals Reports Strong Q3: Will Debt Weigh On Its Future Growth?

November 06, 2024

In-Depth Examination Of 12 Analyst Recommendations For Jazz Pharmaceuticals

October 23, 2024

Billionaire Seth Klarman Sold 64% of Baupost's Stake in Alphabet and Is Piling Into This Historically Cheap and Under-the-Radar Drugmaker

October 18, 2024

Jazz Pharmaceuticals' Zepzelca/Tecentriq Combo Regimen Can Potentially Delay Disease Progression, Extend Survival In Aggressive Form Of Lung Cancer

October 15, 2024

Jazz Artist Bob Holz Signs With SoVibe Entertainment Plus Album Review In September 2024 Issue Of Downbeat Magazine

October 08, 2024

Assessing Jazz Pharmaceuticals: Insights From 12 Financial Analysts

October 04, 2024

FDA-Approved Cannabis-Based Drug Shows Promising Results As A Treatment For War Veterans: Study Finds Improvement In Cognitive, Mood, Pain-Related Symptoms

September 19, 2024

A Closer Look at 12 Analyst Recommendations For Jazz Pharmaceuticals

September 09, 2024

Jazz And Hikma Accused Of Delaying Sleep Disorder Generic Drug To Maintain High Prices

August 28, 2024

'From Five Minutes Of Agony, It's Now Just Seconds,' Says Brazilian Mother Celebrating Free Access To Her Child's Life-Saving CBD Medicine

August 27, 2024

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.